Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

2271

Actual shortage: 53 (2%)
Anticipated shortage: 0 (0%)
Avoided shortage: 19 (1%)
Resolved: 2199 (97%)

Discontinuation Reports

124

To be discontinued: 4 (3%)
Discontinued: 118 (95%)
Reversed: 2 (2%)

Late reports

452 (19%)

Overdue reports

11 (19%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD 2.5MG 8MG TABLET Resolved 2025-02-17 2025-04-01 250519
SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD 2MG 0.625MG TABLET Resolved 2019-08-06 2019-09-10 90876
SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD 2MG 0.625MG TABLET Resolved 2019-11-18 2020-01-22 99106
SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD 0.625MG 2MG TABLET Resolved 2023-08-14 2023-09-06 201744
SANDOZ PIOGLITAZONE 45MG TABLET Resolved 2019-01-16 2019-03-05 72473
SANDOZ PIOGLITAZONE 30MG TABLET Resolved 2019-02-12 2019-04-10 75506
SANDOZ PIOGLITAZONE 15MG TABLET Resolved 2019-05-07 2019-07-24 83265
SANDOZ PIOGLITAZONE 15MG TABLET Resolved 2020-12-07 2021-01-18 129736
SANDOZ PIOGLITAZONE 30MG TABLET Resolved 2021-04-27 2021-06-07 138118
SANDOZ PIOGLITAZONE 15MG TABLET Resolved 2022-04-12 2022-04-20 158702
SANDOZ PIOGLITAZONE 45MG TABLET Resolved 2022-08-18 2022-09-02 167348
SANDOZ PIRFENIDONE CAPSULES 267MG CAPSULE Resolved 2022-04-20 2022-04-28 159091
SANDOZ PIRFENIDONE CAPSULES 267MG CAPSULE Resolved 2024-06-12 2024-10-01 230189
SANDOZ PIRFENIDONE CAPSULES 267MG CAPSULE Resolved 2024-06-17 2024-10-29 230763
SANDOZ PIRFENIDONE TABLETS 267MG TABLET Resolved 2021-11-15 2022-04-28 149309
SANDOZ PIRFENIDONE TABLETS 267MG TABLET Resolved 2021-11-15 2022-04-28 149312
SANDOZ PIRFENIDONE TABLETS 801MG TABLET Resolved 2021-11-15 2022-04-28 149315
SANDOZ PIRFENIDONE TABLETS 267MG TABLET Resolved 2022-11-16 2023-03-03 174985
SANDOZ PIRFENIDONE TABLETS 801MG TABLET Resolved 2024-04-08 2024-06-26 224642
SANDOZ POLYTRIMETHOPRIM 1MG 10000UNIT SOLUTION Resolved 2019-08-14 2019-09-10 91544

Showing 1601 to 1620 of 2271

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000

Showing 1 to 20 of 124